Sex-specific and socioeconomic disparities in the global burden of inflammatory bowel disease in 204 countries, 1990–2021: projections to 2050
Qingtong Li, Yanqi Kou, Mingcheng Zhang, Chunyi Wu, Rongfo Mi, Wantong Jiang, Yufei Cheng, Lei Ge, Ke Yang, Zhe Huang, Yuan Tian, Botao Luo, Yanping Ha, Wanyi Yin, Wei Guo, Wenwei Zhu, Jun Liu, Shicai Ye, Yijie Weng, Jiayuan Wu, Yuping Yang

TL;DR
Inflammatory bowel disease is increasing globally, especially in lower-income regions, with notable differences between sexes and age groups.
Contribution
This study provides a comprehensive global analysis of IBD trends and disparities linked to socioeconomic factors and sex.
Findings
Global crude counts of IBD metrics increased significantly from 1990 to 2021, while age-standardized rates declined.
Low- and middle-SDI regions showed the fastest rise in IBD incidence and prevalence, correlating with increasing SDI.
Females experienced higher disability and prevalence in mid-life and very old age, highlighting sex-specific disparities.
Abstract
Inflammatory bowel disease (IBD) represents a growing global health challenge, necessitating a systematic evaluation of its epidemiological trends and sociodemographic disparities. Using Global Burden of Disease 2021 data, we quantified IBD burden (incidence, mortality, prevalence, disability-adjusted life years [DALYs], years lived with disability [YLDs], and years of life lost [YLLs]) across 204 countries and territories from 1990 to 2021, and projected trends to 2050, evaluating associations with Sociodemographic Index (SDI) and sex disparities. Between 1990 and 2021, global crude counts of incident cases, deaths, prevalence, DALYs, YLDs, YLLs increased by 88.3%, 98.1%, 76.5%, 59.2%, 75.1%, and 50.8%, respectively. However, age-standardized rates (ASRs) of mortality, prevalence, DALYs, YLDs, and YLLs declined by 13.0%, 6.5%, 16.1%, 6.6%, and 21.0%, respectively, contrasting with a…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Bowel Disease · Clostridium difficile and Clostridium perfringens research · Pregnancy and Medication Impact
